These results suggest that DNase I can substantially attenuate disease activity and renal dysfunction in a mouse model of LN, inhibit the activation of NETs in the kidney, which is closely associated with the pathogenesis of the disease, and thereby mitigate renal damage. The gene discussed is DNASE1; the disease is lobular neoplasia.